Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZENA
ZENA logo

ZENA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ZenaTech Inc (ZENA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.580
1 Day change
-2.46%
52 Week Range
7.110
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ZenaTech Inc (ZENA) is not a good buy right now for a Beginner with a long-term preference. The stock has some positive event-driven upside from defense contracts and AI data center expansion, but the current trend is still weak and there is no strong proprietary buy signal. Given the investor is impatient and wants a direct entry decision, the better choice is to wait rather than buy at this level.

Technical Analysis

The technical picture is mixed to bearish. MACD is below zero and still negatively contracting, which points to weak momentum. RSI_6 is neutral at 51.94, so the stock is not oversold enough to suggest an attractive dip-buy setup. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), confirming the broader downtrend. Price is below the key resistance zone near 1.74, with pivot support at 1.472 and lower support at 1.205. The recent pattern also suggests only modest near-term upside, with a 60% probability estimate showing a slight next-day decline and only gradual improvement over the next week and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish, with call activity dominating puts. The open interest put-call ratio of 0.23 and volume put-call ratio of 0.03 indicate traders are heavily favoring upside bets. Implied volatility is very high at 135.57, with historical volatility at 137.19, showing the market expects large price swings. However, despite bullish options sentiment, this alone is not enough to override the weak technical trend for a beginner long-term investor.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
3

Positive Catalysts

  • Recent news is supportive: ZenaTech is pursuing U.S. defense contracts by aligning with Blue UAS standards and working with the Department of Defense, which could improve credibility and future revenue opportunities. The company is also entering the AI data center construction market through ZenaWorx software, with LiDAR-based efficiency improvements and possible beta customer negotiations for a large project. These are meaningful growth catalysts if execution follows through.

Neutral/Negative Catalysts

  • The stock is currently in a bearish technical trend, and there is no AI Stock Picker or SwingMax buy signal today. Hedge funds are neutral and insiders are neutral, so there is no strong ownership-driven support. The share price is weak on the day, down 3.12% in regular trading, and there is no recent congress trading data to provide a bullish signal. The company also lacks usable valuation and financial snapshot data in this dataset, which increases uncertainty.

Financial Performance

Latest quarter financials could not be assessed because the financial snapshot returned an error. As a result, there is no reliable quarterly revenue, earnings, or margin trend to confirm that the new defense and AI data center initiatives are already translating into strong operating growth. The latest quarter season is not available from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price-target trend data was provided, so there is no visible Wall Street upgrade/downgrade momentum to summarize. Based on the available evidence, the Wall Street pros view would likely be cautious: the story has attractive catalysts, but the current price trend and lack of confirmation from signals, ownership trends, and financial data keep the stock in speculative territory rather than a clear buy.

Wall Street analysts forecast ZENA stock price to rise
1 Analyst Rating
Wall Street analysts forecast ZENA stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.625
sliders
Low
7
Averages
7
High
7
Current: 1.625
sliders
Low
7
Averages
7
High
7
Citi
Buy
maintain
$46
AI Analysis
2025-12-22
Reason
Citi
Price Target
$46
AI Analysis
2025-12-22
maintain
Buy
Reason
Citi added an "upside 90-day catalyst watch" on shares of Zenas BioPharma while keeping a Buy rating on the shares with a $46 price target ahead of the early January Phase 3 INDIGO readout in immunoglobulin G4-related disease. Citi believes obexlimab is positioned to show a statistically significant reduction in flares relative to placebo.
Maxim
NULL -> Buy
initiated
$9
2025-06-17
Reason
Maxim
Price Target
$9
2025-06-17
initiated
NULL -> Buy
Reason
Maxim initiated coverage of ZenaTech with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ZENA
Unlock Now

People Also Watch